Protocol 2 included 16,768 GLP-1 receptor agonist initiators and 64,849 SGLT-2 inhibitor initiators
Matza LS, Stewart KD, Land LF, Patel H, Boye KS (2022) Exit interviews examining the patient experience in clinical trials of tirzepatide for treatment of type 2 diabetes
N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome
Missed ARDD
These conditions are extremely rare, with only around 150 documented cases across all three genetic disorders in the medical literature
This receptor profile allows researchers to examine how simultaneous activation of incretin- and glucagon-related pathways affects intracellular signaling, hormone pathway coordination, and broader metabolic system responses